NimbleGen Licenses OGT's Array IP, Companies Ink Supply Agreement | GenomeWeb
NEW YORK (GenomeWeb News) - Oxford Gene Technology has licensed patents covering its oligonucleotide array technology to NimbleGen, based in Madison, Wisc., the companies said today.
 
The companies have also signed a supply agreement under which OGT will have access to NimbleGen’s DNA microarrays for use in its services business. NimbleGen will also be able to make and sell OGT-designed arrays.
 
Financial terms of the agreements were not released.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.